Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
30 hedge funds and large institutions have $7.6M invested in Vaxxinity, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 29 → 30 (+1)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
84% less capital invested
Capital invested by funds: $48.5M → $7.6M (-$40.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$94.5K |
| 2 |
State Street
Boston,
Massachusetts
|
+$91.9K |
| 3 |
Bank of New York Mellon
New York
|
+$58.5K |
| 4 |
VF
Virtu Financial
New York
|
+$30K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PML
Prime Movers Lab
Jackson,
Wyoming
|
-$31.4M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4.45M |
| 3 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$394K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$352K |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$198K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.16K | +$1.39K | +825 | New |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $1K | +$672 | +400 | New |
|
28
Wells Fargo
San Francisco,
California
| $342 | +$10 | +6 | +3% |
|
|
SSB
29
Sandy Spring Bank
Olney,
Maryland
| $140 | +$168 | +100 | New |
|
|
NA
30
NewEdge Advisors
New Orleans,
Louisiana
| $4 | +$5 | +3 | New |
|
|
PML
31
Prime Movers Lab
Jackson,
Wyoming
| – | -$31.4M | -17,603,276 | Closed |
|
|
JMPWA
32
JP Morgan Private Wealth Advisors
San Francisco,
California
| – | -$394K | -199,022 | Closed |
|
|
33
Marshall Wace
London,
United Kingdom
| – | -$352K | -178,258 | Closed |
|
|
GCM
34
Ghisallo Capital Management
Boston,
Massachusetts
| – | -$198K | -100,000 | Closed |
|
35
Two Sigma Investments
New York
| – | -$49K | -24,947 | Closed |
|
36
HighTower Advisors
Chicago,
Illinois
| – | -$20K | -10,483 | Closed |
|
37
BNP Paribas Financial Markets
Paris,
France
| – | -$182 | -92 | Closed |
|
VAXX Hedge Fund Activity: Q4 2022 in Review
30 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q4 2022, worth a combined $7.6M — down 84% from $48.5M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VAXX positions and 7 closed out — a net gain of 1 holder — while 4 added to existing stakes and 8 trimmed.
The largest buyer was Millennium Management, adding an estimated $94.5K. The largest seller was Prime Movers Lab, exiting entirely with an estimated $31.4M sold.
- 30 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q4 2022, up from 29 in Q3 2022.
- Funds reported $7.6M of Vaxxinity, Inc. Class A Common Stock stock for Q4 2022, down 84% quarter-over-quarter.
- 8 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q4 2022 and 7 closed out, a net change of +1 holder.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q4 2022 was Millennium Management, an estimated $94.5K added.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q4 2022 was Prime Movers Lab, an estimated $31.4M sold.
Based on aggregated 13F filings for Q4 2022.